HealthPolitics

STAT+: Up and down the ladder: The latest comings and goings

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 16/10/2026, 14:06:24 UTC.

Briefings

STAT+ highlights Xilio Therapeutics' hiring of Yariv Houvras as chief medical officer, a move following his tenure as senior vice president of clinical and translational development at Tubulis. The article notes that the company seeks to add excitement to its leadership, though the specific impact of this change remains to be observed.

Key points

• Xilio Therapeutics hired Yariv Houvras as chief medical officer, a change noted in the weekly feature highlighting personnel shifts.
• Yariv Houvras previously served as senior vice president of clinical and translational development at Tubulis before joining Xilio.

Context

STAT+ features weekly personnel changes to inform readers about who is entering or leaving key roles at biotech companies. This specific update focuses on Xilio Therapeutics' recruitment strategy.

Limitations

The article provides no specific dates for the hiring, no financial figures, and no data on the company's performance or future plans. The source text does not contain background information on the company's history or the broader market context.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 16/10/2026, 14:07:18 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiejfo23nwqqab6xu2ryyozurmstgqvvgb3tjg5necer2rdvj5cely